Proretina

Development of drugs for treating retinal dystrophy and degeneration

The company is a spin-off of the Spanish National Research Council (CSIC) that takes the advances made in neuroprotection obtained by the Cellular Development, Differentiation, and Degeneration Laboratory (3D Laboratory) of the CIB-CSIC and the Centre for Animal Biotechnology and Genetic Therapy of the Autonomous University of Barcelona and adds value to those advances.

News

No related news.